NCT05637892Not yet recruiting
A Cohort Study of Hydatidiform Mole
A Multi-center Cohort Study of Hydatidiform Mole
Source: ClinicalTrials.gov · Last updated 8 Dec 2022 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The purpose of this study is to construct a cohort for the hydatidiform mole.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 800 (estimated)
- First submitted
- 1 Nov 2022
- Start date
- 1 Dec 2022
- Primary completion date
- 1 Dec 2026
- Lead sponsor
- Women's Hospital School Of Medicine Zhejiang University
- NCT number
- NCT05637892
What you commit to
- Study type: Observational
- Planned participants: 800
- From 1 Dec 2022 to the primary completion date, 1 Dec 2026
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Patients who are unable to cooperate with the investigation such as mental disorders or cognitive impairment
- Patients with other malignancies
Other
- No histopathology diagnosis;
Who the study is looking for
- Patients who are diagnosed with hydatidiform mole (including: complete hydatidiform mole/partial hydatidiform mole; one of twins with hydatidiform mole; ectopic pregnancy hydatidiform mole; macroscopic or microscopic hydatidiform changes indicating early complete or partial hydatidiform mole can not be excluded; atypical placental site nodule) for the first time;
- Age 13-55 years old;
- Obtain informed consent and sign an informed consent form
Age in the registry: 13 years to 55 years · Sex: Female · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.